Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).

Authors

• Marcia S Brose
• Johannes W A Smit
• Chia-Chi Lin
• Masayuki Tori
• Daniel W Bowles
• Francis Worden
• Daniel Hueng-Yuan Shen
• Shih-Ming Huang
• Hui-Jen Tsai
• Maria Alevizaki
• Robin P Peeters
• Shunji Takahashi
• Pavel Rumyantsev
• Rongjin Guan
• Svetlana Babajanyan
• Kirhan Ozgurdal
• Iwao Sugitani
• Fabian Pitoia
• Livia Lamartina

Publication/Presentation Date

9-1-2022

Volume

32

Issue

9

First Page

1059

Last Page

1068

ISSN

1557-9077

Published In/Presented At

Brose, M. S., Smit, J. W. A., Lin, C. C., Tori, M., Bowles, D. W., Worden, F., Shen, D. H., Huang, S. M., Tsai, H. J., Alevizaki, M., Peeters, R. P., Takahashi, S., Rumyantsev, P., Guan, R., Babajanyan, S., Ozgurdal, K., Sugitani, I., Pitoia, F., & Lamartina, L. (2022). Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI). Thyroid : official journal of the American Thyroid Association, 32(9), 1059–1068. https://doi.org/10.1089/thy.2022.0061

Disciplines

Medicine and Health Sciences

PubMedID

35950621

Department(s)

Hematology-Medical Oncology Division

Document Type

Article